Johnson & Johnson’s one-dose vaccine is less effective against the Delta variant, a study suggests.

By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/3hRYqzm

PEPFAR Is Still Without a Leader. H.I.V. Activists Want to Know Why.

By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/3wQBmoV

The Johnson & Johnson one-dose vaccine is less effective against the Delta variant, a study suggests.

By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/3eESyaK

The Johnson & Johnson one-dose vaccine is ineffective against Delta, a study shows.

By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/3kEv5Kw

One Dose of J.&J. Vaccine Is Ineffective Against Delta, Study Suggests

By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/3znkyaX

States and Cities Near Tentative $26 Billion Deal in Opioids Cases

By BY JAN HOFFMAN from NYT Health https://ift.tt/2UlEBrt

How an Unproven Alzheimer’s Drug Got Approved

By BY PAM BELLUCK, SHEILA KAPLAN AND REBECCA ROBBINS from NYT Health https://ift.tt/2V2fsC8